Darzalex

Darzalex (daratumumab) is a monoclonal antibody used in the treatment of multiple myeloma. This subcutaneous formulation is designed for targeted therapy, offering a convenient administration option.

Darzalex is primarily used for the treatment of multiple myeloma, a type of cancer affecting plasma cells. It works by targeting specific proteins on cancer cells, helping to slow down the progression of the disease. Patients often wonder, 'What is Darzalex used for?' and the answer lies in its role in managing this specific type of cancer.

Common effects of Darzalex may include infusion-related reactions, such as fever, chills, and shortness of breath. Some patients may also experience fatigue, nausea, or upper respiratory tract infections. These effects can vary from person to person.

Darzalex should be administered under the supervision of a healthcare professional. It is important to discuss any existing medical conditions or allergies with your healthcare provider before starting treatment. Regular monitoring may be required during therapy.

Darzalex may interact with certain medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances may also interact with Darzalex, so it is advisable to consult with a healthcare professional.